The document discusses the ACCU-CHEK 360 tool and its effectiveness in lowering A1C levels when used collaboratively with patients. It cites a study that found structured self-monitoring of blood glucose using ACCU-CHEK significantly reduced A1C levels in poorly controlled, noninsulin-treated type 2 diabetes patients. The document invites the reader to attend a product theater presentation on using the ACCU-CHEK 360 approach to engage patients and improve outcomes.